|
|
| Quarterly Results |
|
| Vivimed Labs Ltd | | Industry : Pharmaceuticals - Indian - Bulk Drugs & Formln | Chairman : | | Home : Indian Private | Book Value: 7.4280394 | | BSE Code : 532660 | Market Cap: 40.63 | | NSE Code : VIVIMEDLAB | P / E : 0 | |
| |
|
|
|
|
|
|
| (Rs in Cr.) |
|
|
| Type | 3Qtr | 2Qtr | 1Qtr | 4Qtr | | Net Sales | 37.14 | 30.28 | 33.00 | 39.72 | | Other Income | 0.04 | 2.16 | 0.01 | 0.00 | | Total Income | 37.17 | 32.44 | 33.01 | 39.72 | | Total Expenditure | 36.25 | 35.69 | 33.29 | 203.49 | | Operating Profit | 0.92 | -3.25 | -0.28 | -163.77 | | Interest | 13.16 | 11.82 | 10.61 | 8.07 | | Gross Profit | -12.24 | -15.07 | -10.90 | -171.84 | | Depreciation | 4.49 | 4.49 | 4.49 | 95.07 | | Tax | 0.00 | 0.00 | 0.00 | 0.00 | | Deferred Tax | -0.55 | 0.00 | 0.00 | -2.07 | | Reported Profit After Tax | -16.17 | -19.56 | -15.38 | -264.85 |
|
|
|
|
|